PRCT Jul 2024 70.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 09:52AM EDT. Market open.
Loading interactive chart...
- GlobeNewswire
Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic Hyperplasia
Data from the Icahn School of Medicine at Mount Sinai and Potomac Urology presented at the 2024 AUA Annual Meeting highlight Aquablation therapy’s potential to become the new standard of care in BPH for prostates of all sizesSAN JOSE, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced long-term, real-world data sho
- Simply Wall St.
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Just Reported And Analysts Have Been Lifting Their Price Targets
PROCEPT BioRobotics Corporation ( NASDAQ:PRCT ) just released its latest quarterly results and things are looking...
- GuruFocus.com
Director Thomas Krummel Sells 20,000 Shares of PROCEPT BioRobotics Corp (PRCT)
On May 1, 2024, Thomas Krummel, Director at PROCEPT BioRobotics Corp (NASDAQ:PRCT), sold 20,000 shares of the company.
© 2024 Yahoo. All rights reserved.